Galderma R&d

This study tests a drug called nemolizumab in toddlers aged 6 to 23 months with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams or ointments. The goal is to see how the drug moves through the body, if it is safe, and if it helps control the conditio…

This study looks at the safety of using Restylane Lyft with Lidocaine, a hyaluronic acid gel, for a second treatment to improve the chin profile. About 100 adults aged 22 and older will receive the retreatment. The main goal is to track any side effects related to the gel or inje…

This pilot study will test the safety and effectiveness of two injectable gels, GP0122 and GP0124, for reducing lines and wrinkles in the cheek area. About 60 adults with moderate to severe cheek wrinkles will receive the treatment and be followed for 12 months. The main goal is …